Articles from Tenon Medical, Inc.

LOS GATOS, CA / ACCESS Newswire / June 30, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a medical device company dedicated to transforming care for patients with certain sacro-pelvic disorders, announced that it has priced a public offering of securities as described below for aggregate gross proceeds to the Company of approximately $4.2 million, before deducting placement agent fees and other estimated offering expenses payable by the Company.

LOS GATOS, CA / ACCESSWIRE / July 27, 2022 / Tenon Medical, Inc. ("Tenon" or the "Company"), a medical device company that has developed a proprietary, U.S. Food and Drug Administration ("FDA") cleared surgical implant system for sacroiliac joint ("SI Joint") fixation/fusion surgery, today announced plans to release financial results for the second quarter ended June 30, 2022 after market close on Thursday, August 11, 2022. The Company will also hold a conference call the same day at 4:30 p.m. Eastern Time to discuss its financial results in further detail. The call with conclude with a Q&A session.

~ Closes $16 Million IPO and Commences Trading on the Nasdaq ~

LOS GATOS, CA / ACCESSWIRE / May 31, 2022 / Tenon Medical, Inc. ("Tenon" or the "Company"), a medical device company that has developed a proprietary, U.S. Food and Drug Administration ("FDA") cleared surgical implant system for sacroiliac joint ("SI Joint") fixation/fusion surgery, today announced the Company has posted its new corporate presentation accessible via the Company's Investor Relations website at http://ir.tenonmed.com/.

LOS GATOS, CA / ACCESSWIRE / May 25, 2022 / Tenon Medical, Inc. ("Tenon" or the "Company"), a medical device company that has developed a proprietary, U.S. Food and Drug Administration ("FDA") cleared surgical implant system for sacroiliac joint ("SI Joint") fixation/fusion surgery, today announced the Company will participate in The Benchmark Company Healthcare House Call Virtual 1x1 Investor Conference on Thursday, June 2, 2022.

Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence.

LOS GATOS, CA / ACCESSWIRE / April 26, 2022 / Tenon Medical, Inc. ("Tenon" or the "Company"), a medical device company that has developed a proprietary, U.S. Food and Drug Administration ("FDA") cleared surgical implant system for sacroiliac joint ("SI Joint") fixation/fusion surgery, today announced the pricing of its initial public offering of 3,200,000 shares of its common stock at a price of $5.00 per share which reflects a 2 for 1 reverse